TXNIP and atherosclerosis: Finally, mechanistic investigations revealed that vulnerable psEVs promoted endothelial inflammation and atherosclerosis partially through miR‐497‐5p delivery and UCP2 suppression to activate the ROS/TXNIP/NLRP3 pathway.